Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $8,000 | 1 | 70.9% |
| Food and Beverage | $2,007 | 112 | 17.8% |
| Travel and Lodging | $1,033 | 2 | 9.2% |
| Education | $239.07 | 15 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $8,000 | 1 | $0 (2024) |
| Covidien LP | $1,056 | 3 | $0 (2017) |
| GlaxoSmithKline, LLC. | $832.75 | 61 | $0 (2022) |
| Grifols USA, LLC | $254.79 | 12 | $0 (2020) |
| CSL Behring | $194.29 | 11 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $173.59 | 5 | $0 (2022) |
| Insmed, Inc. | $157.39 | 7 | $0 (2022) |
| Abbott Laboratories | $119.39 | 3 | $0 (2024) |
| ADVANCED RESPIRATORY, INC | $64.65 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $61.53 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,119 | 4 | Medtronic, Inc. ($8,000) |
| 2023 | $37.00 | 1 | LivaNova USA, Inc. ($37.00) |
| 2022 | $68.22 | 4 | Insmed, Inc. ($28.53) |
| 2021 | $371.15 | 24 | GlaxoSmithKline, LLC. ($247.74) |
| 2020 | $250.16 | 11 | Grifols USA, LLC ($92.19) |
| 2019 | $529.07 | 31 | GlaxoSmithKline, LLC. ($167.57) |
| 2018 | $562.85 | 34 | GlaxoSmithKline, LLC. ($241.20) |
| 2017 | $1,340 | 21 | Covidien LP ($1,056) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Neuromodulation | ||||||
| 10/18/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Neuromodulation | ||||||
| 10/11/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Grant | Cash or cash equivalent | $8,000.00 | General |
| Category: Drug Infusion Systems | ||||||
| 09/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $76.91 | General |
| Category: Neuromodulation | ||||||
| 07/26/2023 | LivaNova USA, Inc. | Hemolung Cartridge Kit (Device) | Food and Beverage | In-kind items and services | $37.00 | General |
| Category: Devices | ||||||
| 05/19/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 03/21/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Respiratory | ||||||
| 02/22/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: RESPIRATORY | ||||||
| 01/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: RESPIRATORY | ||||||
| 11/09/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Respiratory | ||||||
| 10/05/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.37 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: RESPIRATORY | ||||||
| 07/13/2021 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Education | In-kind items and services | $18.28 | General |
| Category: Cardio-pulmonary | ||||||
| 06/23/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2021 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $11.75 | General |
| Category: Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 337 | 758 | $224,650 | $102,130 |
| 2022 | 16 | 1,099 | 2,014 | $405,680 | $180,208 |
| 2021 | 23 | 1,512 | 2,808 | $569,195 | $256,207 |
| 2020 | 31 | 2,341 | 4,451 | $762,040 | $314,513 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 179 | 368 | $147,200 | $64,011 | 43.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 147 | 379 | $75,800 | $37,723 | 49.8% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 11 | 11 | $1,650 | $395.67 | 24.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 180 | 372 | $148,800 | $67,010 | 45.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 168 | 416 | $83,200 | $36,383 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 162 | 279 | $55,800 | $21,889 | 39.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 102 | 163 | $40,750 | $19,854 | 48.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 106 | 358 | $28,640 | $17,809 | 62.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 66 | $9,900 | $3,203 | 32.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 50 | 50 | $5,000 | $2,213 | 44.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 34 | 54 | $4,050 | $2,193 | 54.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 51 | 51 | $6,120 | $2,100 | 34.3% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 16 | 16 | $4,800 | $1,755 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,800 | $1,662 | 34.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 51 | 51 | $6,120 | $1,520 | 24.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 59 | 61 | $3,050 | $1,213 | 39.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 28 | 28 | $2,100 | $712.37 | 33.9% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 13 | 13 | $1,950 | $440.65 | 22.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 13 | 20 | $600.00 | $250.48 | 41.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 217 | 495 | $198,000 | $96,299 | 48.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 183 | 477 | $95,400 | $43,995 | 46.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 234 | 390 | $78,000 | $29,448 | 37.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 137 | 231 | $57,750 | $28,920 | 50.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 114 | 514 | $38,780 | $16,932 | 43.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 48 | 48 | $14,400 | $6,485 | 45.0% |
About Dr. Alpha Anders, M.D
Dr. Alpha Anders, M.D is a Critical Care Medicine healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114032620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alpha Anders, M.D has received a total of $11,278 in payments from pharmaceutical and medical device companies, with $8,119 received in 2024. These payments were reported across 130 transactions from 23 companies. The most common payment nature is "Grant" ($8,000).
As a Medicare-enrolled provider, Anders has provided services to 5,289 Medicare beneficiaries, totaling 10,031 services with total Medicare billing of $853,058. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Bakersfield, CA
- Active Since 08/21/2006
- Last Updated 07/21/2022
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114032620
Products in Payments
- SYNCHROMEDII (Device) $8,000
- superDimension (Device) $1,056
- TRELEGY ELLIPTA (Drug) $420.87
- Prolastin-C Liquid (Biological) $221.23
- NUCALA (Biological) $205.73
- Zemaira (Biological) $194.29
- BEVESPI AEROSPHERE (Drug) $159.59
- Arikayce (Drug) $157.39
- ANORO (Drug) $97.57
- ETERNA (Device) $90.55
- BREO (Drug) $66.65
- GLASSIA (Biological) $64.80
- The Vest System Model 105 Home Care (Device) $42.09
- INCRUSE (Drug) $41.93
- Adempas (Drug) $40.40
- Hemolung Cartridge Kit (Device) $37.00
- Prolastin-C (Biological) $33.56
- QVAR (Drug) $33.18
- TUDORZA PRESSAIR (Drug) $31.00
- PROCLAIM (Device) $28.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Bakersfield
Dr. Rajan Goyal, M.d, M.D
Critical Care Medicine — Payments: $12,672
Dr. Pramil Vaghasia, Md, MD
Critical Care Medicine — Payments: $6,022
Dr. Ololade Oladimeji, M.d, M.D
Critical Care Medicine — Payments: $1,281
Maricel Zulueta
Critical Care Medicine — Payments: $419.40
Gary Walters, Np, NP
Critical Care Medicine
Felicia Wilson
Critical Care Medicine